Lithium Toxicity and Altered Clearance Following Initiation of Semaglutide in Patients With Bipolar Disorder: A Case Series and Literature Review. [PDF]
J Clin PsychopharmacolAl-Soleiti M +6 more
europepmc +1 more source
Prescribing Trends for Bipolar Disorder Drugs in Alberta, Canada Between 2008 and 2021: Tendances en matière de prescription de médicaments pour le trouble bipolaire en Alberta, au Canada, entre 2008 et 2021. [PDF]
Can J PsychiatryShafiq S +4 more
europepmc +1 more source
Potential Impact of Childhood Abuse on Quality of Life During Mood-Stabilising Treatment in Individuals Living With Bipolar Disorder. [PDF]
Bipolar DisordWrobel AL +13 more
europepmc +1 more source
A Case of Pseudotumor Cerebri Associated with Lithium Use. [PDF]
Turk Psikiyatri DergTürkoğlu Ö +2 more
europepmc +1 more source
Acute and reversible dyskinesias secondary to lithium toxicity: case report and literature review. [PDF]
BMC NeurolFalletti M +5 more
europepmc +1 more source
Global Trends in the Use of Pharmacotherapy for the Treatment of Bipolar Disorder. [PDF]
Curr Psychiatry RepYocum AK, Singh B.
europepmc +1 more source
Treating Neuropsychiatric Conditions in Pediatric Epilepsy: Practical Considerations. [PDF]
Epilepsy CurrDilara Ertenu D, Salpekar JA.
europepmc +1 more source
Is it reasonable to exclude other severe mental illnesses and mood stabilizers in the prediction of suicide? [PDF]
Transl Psychiatryde Souza Júnior SA +4 more
europepmc +1 more source
Reduced risk of cause-specific hospitalisations and all-cause hospitalisation/mortality during treatment with attention-deficit/hyperactivity disorder medications in the course of bipolar disorder: a Swedish registry-based within-subject cohort study. [PDF]
BMJ Ment HealthErmis C +8 more
europepmc +1 more source